Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant FLOT chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma
2009-012608-20Phase 2Active
- Sponsor
- An-Institut für Qualitätssicherung in der operativen Medizin
- Start
- Oct 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil, folinic acid, oxaliplatin and docetaxel in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma, sponsored by An-Institut für Qualitätssicherung in der operativen Medizin. Primary endpoints: Operability and Overall response rate. Started Oct 2009; status: active.
02
Drugs
fluorouracilfolinic acidoxaliplatindocetaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on 2009-012608-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012608-20.